During the past 10years, Clostridium difficile infections (CDI) have become a major public
health challenge. Their epidemiology has changed with a rise in the number of cases and …

Recurrent Clostridium difficile infection represents a burdensome clinical issue whose
epidemiology is increasing worldwide. The pathogenesis is not yet completely known …

Clostridium difficile is a gram-positive, anaerobic bacillus that can cause antibiotic-
associated diarrhea, colitis, and pseudomembranous colitis (PMC). This infection is now …

Clostridium difficile is a Gram-positive bacterium with the capacity of spore generation. The
C. difficile infections, related to antibiotic treatment, have increased in number and severity …

Clostridium difficile infection is an important health problem worldwide and leads to
increased morbidity and mortality, particularly among the elderly population. Antibiotics …

Clostridium difficile infection (CDI) is an increasing problem in hospitalized patients.
Recurrences of disease, despite the recommended treatments with metronidazole or …

Recurrent Clostridium difficile infection (CDI) is a growing problem that poses significant
management challenges. There is no strong evidence to support a particular treatment …

Background Clostridium difficile infection (CDI) recurs in nearly one-third of patients who
develop an initial infection. Recurrent CDI (RCDI) is associated with considerable morbidity …

Research and innovation around Clostridium difficile infection (CDI) has been a
multidisciplinary endeavor since discovery of the organism in 1978. The field of …

Clostridium difficile is a spore-forming gram-positive bacillus, and the leading cause of
antibiotic-associated nosocomial diarrhea and colitis in the industrialized world. With the …